Trials / Unknown
UnknownNCT05364866
CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories
Cryoballoon Ablation Versus Medical Therapy in Patients With Atrial Fibrillation and Heart Failure With Different Ejection Fraction Categories
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Affiliated Hospital of Nantong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is to assess the effectiveness and safety of cryoballoon ablation comparing with medical therapy in patients with atrial fibrillation and heart failure with different ejection fraction categories.
Detailed description
Subjects with atrial fibrillation and heart failure with different ejection fraction categories are devided to either an anti-arrhythmic drug or cryoballoon catheter ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Antiarrhythmic drug Therapy | Propafenone, Sotalol and Amiodarone |
| DEVICE | cryoballoon ablation | Medtronic Arctic Front Advance™ Cardiac CryoAblation Catheters including 23mm and 28mm. |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2022-05-06
- Last updated
- 2023-06-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05364866. Inclusion in this directory is not an endorsement.